華檢醫療(01931.HK)上半年營收達12.7億元 打造"全球增強版以太坊金庫"
格隆匯8月29日丨華檢醫療(01931.HK)公佈中期業績,2025年上半年,集團實現收益人民幣12.70億元,其中,分銷業務營收11.77億元,佔公司總收入比例92.7%。期內,公司母公司擁有人應佔期內溢利人民幣3911.9萬元。
透過多年營運,集團已建立龐大的分銷網絡,覆蓋中國31個省份、直轄市及自治區,醫院覆蓋範圍廣泛。截至2025年6月30日,集團於其已建立的分銷網絡中擁有236名直接客戶(包括醫院及醫療機構)以及1,073個分銷商。截至2025年6月30日,集團亦主要透過在中國的下級分銷網絡覆蓋1,711家三級醫院,進一步提升集團之競爭優勢。
爲把握IVD市場的高增長潛力,集團旨在透過多樣化產品類別,擴大品牌覆蓋範圍,以及擴展分銷網絡及醫院覆蓋範圍以不斷豐富其產品組合。爲實現該等目的,集團擬(i)通過吸納足夠的目標IVD產品以獲得更多的分銷權,建立及維持與知名IVD製造商及供應商的關係;(ii)加強與市區醫院、省市級社區診所及農村地區其他客戶的關係;及(iii)設立新部門並聘請更多銷售人員協助管理分銷覆蓋範圍的擴展。
此外,公司近期與全球數字資產金融服務領導者HashKey集團訂立全球戰略合作框架協議,標誌着公司在鏈上金融與醫療創新資本結合上的重要里程碑。該合作將依託HashKey的合規交易平臺與全球流動性網絡,協助集團執行以太坊(ETH)大宗交易、優化場外交易成本及強化資產管理機制。透過這一合作,集團得以在合規前提下迅速建立並擴充「全球增強版以太坊金庫」,提升資本使用效率併爲後續的代幣化研發項目提供可靠的儲備支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.